Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

There were statistically differences in sex, the incidence of DKA, C-peptide, glycosylated hemoglobin at first diagnosis, blood glucose at first diagnosis, 25OHD level, hospital length of stay, hospitalization costs, and the incidence of polydipsia, polyuria, weight loss, and complicated systemic diseases among the three groups (Table 1).Age difference analysis of each index0: 3 years (n = 236)4 to 9 years (n = 229)10 to 18 years (n = 218)PSex (male)139 (58.9%)a113 (49.3%)b105 (48.1%)b0.04*Onset season Spring49 (20.76%)50 (21.83%)55 (25.23%)0.318 Summer54 (22.88%)65 (28.38%)50 (22.94%) Autumn70 (29.66%)53 (23.14%)47 (21.56%) Winter63 (26.69%)61 (26.64%)66 (30.28%)Family history positivity48 (20.34%)41 (17.90%)41 (18.81%)0.795DKA positivity167 (70.76%)a134 (58.52%)b129 (59.17%)b0.009*DKA degree Mild64 (38.32%)64 (47.76%)60 (46.51%)0.195 Moderate and severe103 (61.68%)70 (52.24%)69 (53.49%)Term infant223 (94.5%)a194 (84.7%)b127 (58.3%)c< 0.001*Breast milk before 6 months190 (80.5%)176 (76.9%)163 (74.8%)0.332HbA1c (%)11.19 (2.44)a12.36 (2.47)b12.24 (3.09)b< 0.001*C-peptide (nmol/L)0.31 (0.14,0.42)a0.52 (0.24,0.46)b0.74 (0.28,0.75)b< 0.001*Blood glucose (mmol/L)23.43 (6.61)a22.94 (7.37)a20.36 (7.21)b< 0.001*25OHD (ng/ml)20.73 (9.54)a17.79 (7.19)b17.08 (6.55)b< 0.001*Hospital length of stay (days)15.88 (6.55)a14.32 (6.07)b11.60 (5.45)c< 0.001*Disease course (days)5 (0,15.5)5 (0,15)4.5 (0,12)0.922Cost (China Yuan)7481.52 (6166.42,10,495.78)a6819.28 (5304,8492.66)b6226.4 (4298.39,8570.15)b< 0.001*Polydipsia206 (87.29%)a192 (83.84%)a155 (71.10%)b0.002*Polyuria191 (80.93%)a179 (78.17%)a124 (56.88%)b< 0.001*Weight loss56 (23.73%)a93 (40.61%)b76 (34.86%)b< 0.001*Delayed diagnosis83 (35.2%)a50 (21.8%)b41 (18.8%)b< 0.001*ICA positivity2 (0.8%)a12 (5.2%)b14 (6.4%)b< 0.001*IAA positivity42 (17.8%)a26 (11.3%)b96 (44%)c< 0.001*GADA positivity140 (59.3%)a138 (60.2%)a68 (31.1%)b< 0.001*a,b,c means Statistical difference between groups* means P value< 0.05, statistically significant among the three groups25OHD 25-hydroxyvitamin D, HbA1c Hemoglobin A1C, DKA Diabetic ketoacidosis, ICA Islet cell autoantibody, IAA Insulin autoantibody, GADA Glutamic acid decarboxylase antibody

Source: Difference analysis of each age group. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The patients were divided into three groups according to age: Group I, 0 to 3 years; Group II, 4 to 9 years; and Group III, 10 to 18 years.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Clinical characteristics of 683 children and adolescents, aged 0 to 18 years, newly diagnosed with type 1 diabetes mellitus in Henan Province: a single-center study

Study design awaiting verification · BMC Pediatrics · 2023

Original publication title

Clinical characteristics of 683 children and adolescents, aged 0 to 18 years, newly diagnosed with type 1 diabetes mellitus in Henan Province: a single-center study

Ai Huang; Qiong Chen; Wei Yang; Yan Cui; Qingzhi Wang; Haiyan Wei

© The Author(s) 2023

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The incidence of DKA among children and adolescents in the Henan Province is very high. Moreover, DKA can be easily delayed in diagnosis. Newly diagnosed infants with T1DM are more likely to present with DKA, suffer more severe metabolic disorders, endure longer hospital stays, and accrue higher medical costs.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Type 1 diabetes mellitus (T1DM) is a common chronic systemic disease that threatens the health of children worldwide. Diabetic ketoacidosis (DKA) is the most severe acute complication of diabetes and can lead to death. This study aimed to explore the epidemiological features, clinical manifestations, and risk factors for DKA in children and adolescents newly diagnosed with T1DM in the Department of Endocrinology of the Children’s Hospital of Henan Province.

Source: Background

Abstract: What methods does the paper describe?

Medical records of 683 children and adolescents newly diagnosed with T1DM in our center from March 2014 to November 2021 were retrospectively analyzed. The data included the general condition, laboratory indexes, and clinical symptoms. The patients were divided into three groups according to age: Group I, 0 to 3 years; Group II, 4 to 9 years; and Group III, 10 to 18 years.

Source: Methods

Abstract: Results

The incidence of DKA was 62.96% and was highest in Group I. Group I had the lowest C-peptide and hemoglobin A1c, but the highest blood glucose at first diagnosis, and 25-hydroxyvitamin D3 levels, hospitalization lengths, and medical costs. 25.5% of the children were delayed in diagnosis. Logistic regression analysis showed that elevated HbA1c levels and hyperglycemia were independent risk factors for DKA. On the other hand, C-peptide and 25: hydroxyvitamin D were protective factors for DKA.

Source: Results

Abstract: Conclusions

The incidence of DKA among children and adolescents in the Henan Province is very high. Moreover, DKA can be easily delayed in diagnosis. Newly diagnosed infants with T1DM are more likely to present with DKA, suffer more severe metabolic disorders, endure longer hospital stays, and accrue higher medical costs.

Source: Conclusions
Authors’ abstract

Background

Type 1 diabetes mellitus (T1DM) is a common chronic systemic disease that threatens the health of children worldwide. Diabetic ketoacidosis (DKA) is the most severe acute complication of diabetes and can lead to death. This study aimed to explore the epidemiological features, clinical manifestations, and risk factors for DKA in children and adolescents newly diagnosed with T1DM in the Department of Endocrinology of the Children’s Hospital of Henan Province.

Methods

Medical records of 683 children and adolescents newly diagnosed with T1DM in our center from March 2014 to November 2021 were retrospectively analyzed. The data included the general condition, laboratory indexes, and clinical symptoms. The patients were divided into three groups according to age: Group I, 0 to 3 years; Group II, 4 to 9 years; and Group III, 10 to 18 years.

Results

The incidence of DKA was 62.96% and was highest in Group I. Group I had the lowest C-peptide and hemoglobin A1c, but the highest blood glucose at first diagnosis, and 25-hydroxyvitamin D3 levels, hospitalization lengths, and medical costs. 25.5% of the children were delayed in diagnosis. Logistic regression analysis showed that elevated HbA1c levels and hyperglycemia were independent risk factors for DKA. On the other hand, C-peptide and 25: hydroxyvitamin D were protective factors for DKA.

Conclusions

The incidence of DKA among children and adolescents in the Henan Province is very high. Moreover, DKA can be easily delayed in diagnosis. Newly diagnosed infants with T1DM are more likely to present with DKA, suffer more severe metabolic disorders, endure longer hospital stays, and accrue higher medical costs.

Publication and source details

Original title: Clinical characteristics of 683 children and adolescents, aged 0 to 18 years, newly diagnosed with type 1 diabetes mellitus in Henan Province: a single-center study

Ai Huang; Qiong Chen; Wei Yang; Yan Cui; Qingzhi Wang; Haiyan Wei

BMC Pediatrics · 2023

© The Author(s) 2023https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T08:02:36.153869+00:00

DOI: 10.1186/s12887-023-03847-z · PMC9869500